PubMed期刊
期刊
会议
图书
作者:Newman Charles , Ajay Vamadevan S , Srinivas Ravi ...
来源:[J].Journal of pharmaceutical policy and practice, 2016, Vol.9, pp.16PubMed
摘要:India shoulders the greatest global burden of cardiovascular diseases (CVDs), which are the leading cause of mortality worldwide. Drugs are the bedrock of treatment and prevention of CVD. India's pharmaceutical industry is the third largest, by volume, globally, but access to CVD...
作者:Houston Adam R , Beall Reed F , Attaran Amir
来源:[J].Journal of pharmaceutical policy and practice, 2016, Vol.9, pp.15PubMed
摘要:Exorbitant price increases for critical off-patent medicines have received considerable media attention in recent months, leading to an investigation by the U.S. Senate. However, much of this attention has focused upon the companies that initiated the price increases, all of whom...
作者:Trap Birna , Kikule Kate , Vialle-Valentin Catherine ...
来源:[J].Journal of pharmaceutical policy and practice, 2016, Vol.9, pp.18PubMed
摘要:Since its inception, the Uganda National Drug Authority (NDA) has regularly inspected private sector pharmacies to monitor adherence to Good Pharmacy Practices (GPP). This study reports findings from the first public facility inspections following an intervention (SPARS: Supervis...
作者:Shroff Zubin , Bigdeli Maryam , Babar Zaheer-Ud-Din ...
来源:[J].Journal of pharmaceutical policy and practice, 2016, Vol.9, pp.19PubMed
摘要:This editorial introduces a series of case studies that together highlight the use of health market interventions to improve access to medicines in low-and-middle income countries (LMICs). It underscores the added value of using a systems approach for a holistic understanding of ...
作者:Kaae Susanne , Sporrong Sofia Kälvemark , Traulsen Janine Morgall ...
来源:[J].Journal of pharmaceutical policy and practice, 2016, Vol.9, pp.20PubMed
摘要:In 2014, a qualitative multi-country research project was launched to study the reasons behind the high use of antibiotics in regions of Southeast Europe by using previously untrained national interviewers (who were engaged in other antibiotic microbial resistance-related investi...
作者:Trap Birna , Ladwar Denis Okidi , Oteba Martin Olowo ...
来源:[J].Journal of pharmaceutical policy and practice, 2016, Vol.9, pp.21PubMed
摘要:Uganda introduced a multipronged intervention, the supervision, performance assessment, and recognition strategy (SPARS), to improve medicines management (MM) in public and not-for-profit health facilities. This paper, the first in a series, describes the SPARS intervention and r...
作者:Nsabagasani Xavier , Ogwal-Okeng Japer , Hansen Ebba Holme ...
来源:[J].Journal of pharmaceutical policy and practice, 2016, Vol.9, pp.22PubMed
摘要:The Integrated Management of Childhood Illnesses is the main approach for treating children in more than 100 low income countries worldwide. In 2007, the World Health Assembly urged countries to integrate 'better medicines for children' into their essential medicines lists and tr...
作者:Beyene Kebede , Aspden Trudi , Sheridan Janie
来源:[J].Journal of pharmaceutical policy and practice, 2016, Vol.9 (1), pp.23PubMed
摘要:Prescription medicine sharing has been defined as the lending of medicines (giving prescription medicines to someone else) or borrowing of medicines (being given and using a medicine prescribed for another person). This qualitative study explored the views of patients, to elicit ...
作者:Aravamuthan Anandhasayanam , Arputhavanan Mohanavalli , Subramaniam Kannan ...
来源:[J].Journal of pharmaceutical policy and practice, 2017, Vol.10, pp.1PubMed
摘要:Due to the lack of clear, comprehensive, and rational drug policy, the production of pharmaceutical preparations in India is distorted for the most part. Indian markets are flooded with more than 70,000 formulations, compared to approximately 350 formulations listed in the World ...
作者:Kaplan Warren A , Beall Reed F
来源:[J].Journal of pharmaceutical policy and practice, 2017, Vol.10, pp.3PubMed
摘要:Lack of access to insulin and poor health outcomes are issues for both low and high income countries. This has been accompanied by a shift from relatively inexpensive human insulin to its more expensive analogs, marketed by three to four main global players. Nonetheless, patent-b...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×